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Background: Bats are a major reservoir of emerging infectious viruses. Many of these viruses are highly pathogenic
to humans however bats remain asymptomatic. The mechanism by which bats control viral replication is unknown.
Here we utilize an integrated approach of proteomics informed by transcriptomics to compare the response of
immortalized bat and human cells following infection with the highly pathogenic bat-borne Hendra virus (HeV).
Results: The host response between the cell lines was significantly different at both the mRNA and protein levels.
Human cells demonstrated minimal response eight hours post infection, followed by a global suppression of mRNA
and protein abundance. Bat cells demonstrated a robust immune response eight hours post infection, which led to
the up-regulation of apoptosis pathways, mediated through the tumor necrosis factor-related apoptosis inducing
ligand (TRAIL). HeV sensitized bat cells to TRAIL-mediated apoptosis, by up-regulating death receptor transcripts. At
48 and 72 hours post infection, bat cells demonstrated a significant increase in apoptotic cell death.
Conclusions: This is the first study to comprehensively compare the response of bat and human cells to a highly
pathogenic zoonotic virus. An early induction of innate immune processes followed by apoptosis of virally infected
bat cells highlights the possible involvement of programmed cell death in the host response. Our study shows for
the first time a side-by-side high-throughput analysis of a dangerous zoonotic virus in cell lines derived from
humans and the natural bat host. This enables a way to search for divergent mechanisms at a molecular level that
may influence host pathogenesis.Background
Emerging infectious diseases pose a significant threat to
human and animal welfare. Many emerging and re-
emerging infectious diseases are zoonoses derived from
wildlife, particularly bats [1,2]. Bats are now recognized as
a major reservoir of zoonotic agents. High profile exam-
ples include the henipaviruses (Hendra and Nipah) [3-5],
severe acute respiratory syndrome-like coronavirus [6,7],
Ebola virus [8] and most recently the Middle East respira-
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unless otherwise stated.as a reservoir for zoonotic viruses was first recognized
with the emergence of Hendra virus (HeV) in northern
Australia in 1994. In two independent spillover events,
HeV claimed the lives of 15 horses and two humans [3,4].
Approximately four years after HeV emerged, a related
paramyxovirus, designated Nipah virus (NiV), emerged in
farmed pigs in Malaysia. Between 1998 and 1999, this
virus claimed the lives of 105 humans and resulted in the
culling of over one million pigs [5]. NiV outbreaks occur
annually in Bangladesh with cases of direct human-to-
human transmission also reported. Bats of the Pteropus
genus are the natural reservoir of both HeV and NiV.
Despite the fact that many of the zoonotic viruses har-
bored by bats are highly pathogenic to their spillover
hosts, bats remain clinically unaffected and rarely display
any signs of disease. Some rabies-like viruses are theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Wynne et al. Genome Biology 2014, 15:532 Page 2 of 21
http://genomebiology.com/2014/15/11/532notable exception [11,12]. The mechanism by which bats
control viral replication remains largely unknown. Des-
pite the absence of clinical disease, bats are capable of
shedding virus and triggering subsequent zoonotic trans-
mission. This situation implies bats are capable of con-
trolling viral replication, but not eliminating it. Studies
on Ebola have demonstrated that bat lung fibroblasts
(derived from the Mexican free-tailed bat) are capable of
maintaining a low-level persistent infection with wild-
type Ebola Zaire [13]. Recent studies have demonstrated
that genes involved in innate immunity have evolved
rapidly under positive selection within the Australian
black flying fox (Pteropus alecto), indicative of co-
evolution between virus and host [14]. However, in-
depth knowledge about the antiviral response of bats is
still lacking, as are the reagents necessary to study these
non-model species. The present study addresses this
knowledge gap by comparing the response of P. alecto
with humans following HeV infection. As the natural
reservoir of HeV, P. alecto remains clinically asymptom-
atic. By contrast, zoonotic transmission of HeV to horses
and humans is often fatal [15].
Genomic resources are now available for a number of
bat species, including whole draft genome sequences
[14,16-18] and de novo assembled transcriptomes
[19,20]. A draft genome sequence for the P. alecto was
released in 2013 [14]. However, to date, no studies have
examined the antiviral response of this species - or any
other bat species - to infectious viruses at either the
transcriptome or proteome level. The study of infectious
agents in any non-model organism by high-throughput
techniques is severely constrained by the quality and
availability of gene model annotations, particularly in the
field of proteomics. While the draft P. alecto genome
was annotated using a combination of homology, de
novo prediction and transcriptomics [14], continual re-
finement is necessary. To circumvent the reliance on
high-quality annotation models, we recently developed
proteomics informed by transcriptomics (PIT) analysis.
This technique collects RNA-sequencing (RNAseq) and
quantitative high-throughput proteomics data simultan-
eously, then uses the transcriptomic data to refine and
inform the proteomics analysis. We have previously
demonstrated that this combined approach sidesteps the
issue of bioinformatics annotation and enables the ana-
lysis of any species on a similar footing to humans [21].
Using stable isotope incorporation of amino acids in cell
culture (SILAC) and RNAseq transcriptomics, we compared
the response of kidney cells derived from human and the
Australian black flying fox to HeV infection at 8 and 24 h.
Because of the paucity of well-characterized primary cell
lines from the Australian black flying fox, we chose to utilize
immortalized cells lines from bats (known as PaKiT03) and
humans (HEK293T). Attempts were made to choose cellsthat were transcriptionally and phenotypically similar. Both
cell lines were derived from the kidney, immortalized using
viral antigens, and are supportive of HeV replication.
We found that the response of HEK293T cells was sig-
nificantly different to PaKiT03 cells. The HEK293T cells
showed little transcriptional or proteomic response to
HeV at 8 h post infection (hpi), followed by a global sup-
pression in protein abundance at 24 hpi. By contrast,
PaKiT03 cells initially underwent activation of NF-kappa-
B (NF-κB) at 8 hpi, followed by the induction of extrinsic
apoptosis pathways at 24 hpi. Further analysis of the re-
sponses after 48 and 72 h of HeV infection revealed that
PaKiT03 cells, but not HEK293T cells, underwent apop-
totic cell death. In addition, our study provides proteomic
evidence for over 5,000 genes in the P. alecto genome, in-
cluding several hundred previously unannotated genes. To
our knowledge, this is the first study to examine the tran-
scriptional and proteomic response to HeV in any cell
type. Furthermore, this study represents the first side-by-
side transcriptomic and proteomic analysis of a single
virus in two relevant host species. This study generates
valuable knowledge concerning the divergent response of
a reservoir and susceptible host to a highly pathogenic
bat-borne virus.
Results
HeV transcription comparison between cell lines
Virus nucleocapsid (N) protein was detectable in increasing
numbers of cells at 8 and 24 hpi (Figure 1A-F). Viral-
induced syncytia were observed at 24 hpi in HEK293T cells
(Figure 1F), but not in PaKiT03 cells (Figure 1C). RNAseq
reads from both cell lines were mapped to the HeV genome
using TopHat. We randomly selected one million mapped
reads from PaKiT03 and HEK293T cells at 24 hpi to enable
a side-by-side comparison of levels of expression from HeV
genes in each cell line (Figure 1G). Comparing gene expres-
sion in the two species cell lines revealed similar numbers
of reads mapped against the N and matrix protein (M),
with differences in all the other genes (Figure 1G,H). A
steep decline in the abundance of transcripts at the M-F
gene boundary was observed in both cell lines.
HeV induces differential gene and protein expression
A total of 222,569 and 285,918 transcripts (with a pre-
dicted open reading frame (ORF) >200 nucleotides) were
assembled de novo for the PaKiT03 and HEK293T cells,
respectively. Differential expression analysis of de novo as-
sembled transcripts revealed that the overall response to
HeV was distinct between cell lines (Figure 2A). In the
PaKiT03 cells, HeV infection induced the expression of
over 200 transcripts at 8 hpi and over 600 transcripts at
24 hpi (Figure 2A, Additional file 1). By contrast, only 8
and 31 transcripts were up-regulated at 8 and 24 hpi in
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Figure 1 HeV infection and transcription in bat and human cells. Confocal microscopy was used to visualize HeV-infected cells. Nuclei are stained
with 4′,6-diamidino-2-phenylindole dihydrochloride, and HeV-N protein was immunodetected with an anti-N polyclonal antibody. PaKiT03 cells at (A)
0 hpi, (B) 8 hpi and (C) 24 hpi are shown. HEK293T cells infected with HeV for (D) 0 hpi, (E) 8 hpi and (F) 24 hpi are shown. Scale bar is 30 μm. (G)
Transcription profile of HeV in PaKiT03 and HEK293T at 24 hpi. (H) Genome structure of HeV. bp, base pairs; F, fusion protein; G, glycoprotein
(attachment protein); L, large protein (polymerase); M, matrix protein; N, nucleocapsid; P, phosphoroprotein (includes proteins V, W and C).
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up-regulated at 24 hpi. The proteomic response also differed
significantly between the two cell lines (Figure 2B). Most
notably, in HEK293T cells over 1,500 proteins were down-
regulated at 24 hpi, whereas only 213 proteins were down-
regulated in PaKiT03 cells at this time point (Additional
file 1). Of the 100 proteins that were significantly induced in
PaKiT03 cells at 8 and/or 24 hpi, 17 were also significantly
up-regulated at the mRNA level (Additional file 1). Many of
these proteins have proven roles in innate immunity, includ-
ing the transcription factor CCAAT/enhancer-binding pro-
tein delta (CEBPD), the interferon (IFN)-stimulated gene
ISG20, receptors CD40 and CD44, and complement com-
ponent C3. By contrast, no proteins were up-regulated at
both the protein and mRNA level in the HEK293T cells.
Furthermore, with one exception in the PaKiT03 cells
(SLC12A2), the proteins down-regulated at 8 and/or 24 hpiwere not significantly down-regulated at the mRNA level for
either cell line. A full list of Trinity transcript and protein
expression statistics are provided as Additional files 2
(PaKiT03) and 3 (HEK293T).
Using our PIT-based approach we were able to detect a
large number of genes and proteins not currently in the
UniProt lists for P. alecto. A total of 263 Trinity-specific
proteinGroups were identified, which represent potentially
novel or alternative protein-coding genes previously not
identified in the P. alecto genome. Two notable genes iden-
tified by this strategy, that were also differentially expressed,
were CEBPD and the gene for tumor necrosis factor (TNF)
receptor superfamily 26 (TNFRSF26).
Divergent responses of orthologous transcripts
Next we identified and compared the expression of ortho-
















































Figure 2 Statistics of differential expression. (A) Differential expression of Trinity transcripts at 8 and 24 hpi was assessed as pairwise comparisons
to 0 hpi. The number and overlap of significantly differentially expressed transcripts (adjusted P <0.05) for 8 and 24 hpi are illustrated as two-way
proportional Venn diagrams. Venn diagrams are organized in a 2 × 2 matrix where up- and down-regulated statistics are given in the columns and the
cell type is given in the rows. (B) Differential expression of Trinity proteins were defined as proteinGroups with SILAC ratios ≥2 fold relative to 0 hpi.
Two-way proportional Venn diagrams for proteins differentially expressed at 8 and/or 24 hpi are illustrated as for (A).
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scripts for both cell lines. All PaKiT03 and HEK293T
Trinity transcripts with >70% similarities to the same hu-
man gene were obtained by Basic Local Alignment Search
Tool (BLAST). Over 10,000 orthologous transcripts were
identified by this strategy (Additional file 4). We first ex-
amined the correlation in baseline mRNA expression (at 0
hpi) between the cell lines (Figure 3A). Because SILAC is
a relative quantification method we could not compare
the baseline protein expression between the cell lines. A
Pearson’s correlation coefficient of 0.75 demonstrated that
orthologous transcripts showed similar baseline mRNA
expression prior to HeV infection. Despite this, at 8 and
24 hpi the correlation in mRNA expression between
orthologous transcripts fell significantly (Figure 3B). Simi-
larly, at the protein level there was poor correlation in
relative protein abundance of orthologous transcripts at 8
and 24 hpi (Figure 3C). Moderate agreement in mRNA
fold change and relative protein abundance was, however,
observed between 8 and 24 hpi within each cell line
(Figure 3B,C). A heatmap of all orthologous transcripts
that were significantly differentially expressed - at one or
more time point – confirmed that the response was simi-
lar at 8 and 24 hpi within each cell line, but differed be-
tween cell lines (Figure 3D).
Enrichment of immune and TNF apoptotic pathways in
PaKiT03 cells
Gene Ontology (GO) enrichment analysis was performed
on the combined list of transcripts and proteins that were
either up- or down-regulated at one or more time points.
Proteins and transcripts that were up-regulated in thePaKiT03 cells at 8 and/or 24 hpi were broadly involved in
response to external stimulus [GO:0009605], response to
stress [GO:0006950], defense response [GO:0006952], regu-
lation of apoptotic processes [GO:0042981] and immune
system process [GO:0002376] (Figure 4A, Additional file 5).
Transcript and protein sets were also subjected to Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway
mapping. Many of the up-regulated PaKiT03 transcripts
and proteins were mapped to TNF signaling (ko4668), NF-
κB signaling (ko04064) and cytokine-cytokine receptor inter-
action (ko04060) pathways (Figure 4B, Additional file 6).
A subset of transcripts involved in apoptosis and TNF
signaling (Figure 4C), including TNFRSF10A (DR4), TNF
RSF11B, CD40 (also known as TNFR5), CASP13 and
TNFAIP3 (A20), were chosen for validation using quantita-
tive PCR (qPCR). In all cases, the differential expression was
confirmed, although the magnitude of the fold change was
less by qPCR compared to RNAseq (Figure 4D-H). Due to
the paucity of bat specific and cross-reactive antibodies, we
could only examine the expression of two proteins - CD40
and TNFAIP3 - by Western blotting in the PaKiT03 cells.
CD40 was up-regulated over two-fold at the protein level in
the SILAC analysis (Figure 4I). No peptides were found for
TNFAIP3 within the SILAC analysis, however considering
its mRNA was significantly up-regulated, we examined its
protein expression with Western blot nonetheless. Both pro-
teins demonstrated differential expression at either 8 and/or
24 hpi, similar to their mRNA expression (Figure 4J).
Interferon production and signaling in HEK293T cells
GO enrichment of HEK293T proteins and transcripts
up-regulated at 8 and/or 24 hpi revealed enrichment for
Log10 SILAC ratio 
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Figure 3 (See legend on next page.)
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Figure 3 Relationship between mRNA and protein expression of orthologous transcripts. (A) Scatterplot illustrating the relationship in
baseline (0 hpi) mRNA expression as log10 normalized fragments per kilobase of transcript per million mapped reads (FPKM) for all ortholog
transcripts (identity >70%). Pearson’s correlation coefficient is indicated in the top right hand corner. (B) Scatterplot matrix of the correlation
between transcript expression (log2-fold change) at 8 and 24 hpi in PaKiT03 and HEK293T cells. Pearson’s correlation coefficients are given in
upper boxes. Simple linear regression models were fitted and are illustrated as red lines through each scatterplot. (C) Scatterplot matrix of the
correlation between protein expression (log10 SILAC ratio) at 8 and 24 hpi in PaKiT03 and HEK293T cells. Pearson’s correlation coefficients are
given in the upper boxes. Simple linear regression models were fitted and are illustrated as red lines through each scatterplot. (D) Heatmap of
orthologous transcripts that were significantly differentially expressed at 8 and/or 24 hpi in either cell line. Expression values for transcripts are
given as log2-fold change.
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type I IFN [GO:0034340] and defense response to virus
[GO:0051607] (Figure 5A, Additional file 5). Few tran-
scripts and proteins from the HEK293T up-regulated set
were mapped to known KEGG pathways, which included
the lysosome pathway (ko04142) (Figure 5B, Additional
file 6). We validated the expression of three human tran-
scripts (IFNB1, IFIT2 and IFIT3) that contributed to the
over-representation of the type I IFN response. All three
transcripts demonstrated significant up-regulation at 24
hpi by qPCR (Figure 5C-E).
HeV up-regulates pro-apoptotic pathways in PaKiT03 cells
Considering the enrichment of apoptosis-related genes
within the PaKiT03 cells, we next examined if the ex-
pression of transcripts and proteins involved in the
apoptotic response differed between the cell lines. Apop-
tosis, or programmed cell death, is an important mech-
anism by which the host can eliminate virus-infected
cells. Apoptosis can be triggered through intrinsic (mito-
chondrial-dependent) or extrinsic signaling pathways. In
the present study, a number of genes/proteins involved
in the extrinsic TNF receptor-associated inducing ligand
(TRAIL)-mediated apoptosis signaling pathway were in-
duced at 24 hpi in the PaKiT03 but not HEK293T cells
(Figure 4C). TRAIL-mediated apoptosis occurs through
binding of the trimerized ligand to its functional death
receptor (DR4/TNFRSF10A or DR5/TNFRSF10B). This
is followed by recruitment of the Fas-associated death
domain, mediated through a death domain, which in-
duces the sequential activation of caspase 8 (from its
pro-caspase precursor) and caspase 3, ultimately leading
to apoptosis-mediated cell death (Figure 6A).
A single peptide derived from the P. alecto TRAIL protein
was found to be induced over 2-fold at 24 hpi in the
PaKiT03 cells (Figure 6B). The fact that TRAIL is often se-
creted as a soluble form could explain why we only observed
a single peptide. This peptide was detected when spectra
were searched against the P. alecto official UniProt list of
proteins and not the Trinity transcriptome-derived protein
list. Furthermore, mRNA up-regulation of the functional
TRAIL receptor (TNFRSF10A/DR4) was demonstrated by
RNAseq and qPCR at 8 and 24 hpi (Figure 4E). In a longer
time course experiment we demonstrated that TNFRSF10A/DR4 mRNA, but not TRAIL, was further induced at 48 and
72 hpi (Figure 6C). A transcript encoding the pro-apoptotic
enzyme caspase 13 was also induced at 8 and 24 hpi in the
PaKiT03 cells (Figure 4D). Caspase 13 mRNA was also
further induced at 48 and 72 hpi in the PaKiT03 cells
(Figure 6C). Other genes and proteins with proven roles in
intrinsic apoptosis processes, such as bcl2 binding compo-
nent 3 (BBC3) and baculoviral IAP repeat containing 3
(BIRC3), were also induced in PaKiT03 cells in response to
HeV (Figure 4C).
Inhibitors of apoptosis in PaKiT03 cells
Interestingly, we also observed up-regulation of the two
anti-apoptotic components within HeV-infected PaKiT03
cells, the TRAIL decoy receptor osteoprotegerin (TNFR
SF11B) and the ubiquitin ligase A20 (TNFIAP3). TNF
RSF11B was induced at the mRNA level at both 8 and 24
hpi (Figure 4F). To further examine the role of anti-
apoptotic components, a long time course experiment was
performed on PaKiT03 cells. TNFRSF11B continued to be
up-regulated at 48 and 72 hpi (Figure 6C). Acting as a decoy
receptor, TNFRSF11B is capable of inhibiting TRAIL-
mediated apoptosis as well as NF-κB activation. In a similar
vein, TNFIAP3 also inhibits TRAIL-induced apoptosis in
certain cells, through poly ubiquitination of the receptor-
interacting protein 1 (RIP1) and inhibition of caspase 8
cleavage. In this study TNFIAP3 mRNA was significantly in-
duced at 8 and, to a lesser extent, 24 hpi in PaKiT03 cells,
but not in HEK293T cells (Figure 4H). Western blot of
TNFIAP3 revealed an increase in protein abundance at 8
hpi in bat cells (Figure 4J). TNFIAP3 itself is an NF-κB-
activated protein that plays an important role in suppressing
NF-κB activity through a negative feedback mechanism.
Again, no differential expression of TNFIAP3 mRNA/pro-
tein was observed in the HEK293Tcells.
Anti-apoptotic signals in HEK293T cells
In contrast to the up-regulation of TRAIL and its down-
stream components in PaKiT03 cells, a down-regulation of
proteins involved in both the intrinsic and extrinsic apop-
tosis pathways was observed in HEK293T cells at 24 hpi.
Indeed, the pro-apoptotic proteins Bcl2 antagonist of cell
death (BAD), caspase 2 and TNFR1-associated death do-
main protein were down-regulated at 24 hpi in HEK293T
Figure 4 (See legend on next page.)
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Figure 4 Activation of apoptosis pathways in HeV-infected PaKiT03 cells. (A) GO terms enriched in the up-regulated genes/proteins in PaKiT03
cells were analyzed and visualized using REVIGO, where redundant GO terms are removed. The size of the circle represents the number of enriched
child GO terms contributing to the parent term. The circle color represents the uncorrected log10 P-value for each parent GO term. Semantic space is
the result of multi-dimensional scaling where similar GO terms cluster together. A full list of enriched GO terms, including false discover rate-corrected
P-values, are presented in Additional file 5. (B) Top 10 most over-represented KEGG pathways, and the number of significantly differentially expressed
genes/proteins contributing to each pathway. The full list of over-represented KEGG pathways is presented in Additional file 6. (C) Expression profile of
significantly up-regulated genes/proteins in the PaKiT03 cells which were assigned to the GO term regulation of apoptotic process [GO:0042981] or
apoptotic process [GO:0006915]. Gray cells represent proteins where no peptides were observed. Expression values for mRNA are given as log2-fold
change, while expression values for proteins are normalized SILAC ratios. Validation of RNAseq differential expression with real-time quantitative PCR
(qPCR) for (D) CASP13, (E) TNFRSF10A, (F) TNFRSF11B, (G) CD40 and (H) TNFAIP3/A20 in PaKiT03 cells. Real-time PCR differential expression was
calculated based on relative expression to 0 hpi and normalized to GAPDH. Log2-fold change is presented; *P <0.05, **P <0.01. (I) Relative protein
expression profile of CD40 in PaKiT03 cells measured by SILAC. (J) Protein expression profile of CD40 and TNFAIP3/A20 in PaKiT03 cells measured by
Western blot. β2-tubulin served as the load control.
KEGG pathway No of 
mapped 
genes 
ko01100 Metabolic pathways 5 
ko04142 Lysosome  3 
ko00140 Steroid hormone biosynthesis  2 
ko00830 Retinol metabolism  2 
ko00330 Arginine and proline metabolism  1 
ko03440 Homologous recombination  1 
ko04612 Antigen processing and presentation  1 
ko00100 Steroid biosynthesis  1 
ko04146 Peroxisome  1 
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Figure 5 Interferon production and signaling in HeV-infected HEK293T cells. (A) GO terms enriched in the up-regulated genes/proteins in
HEK293T cells were analyzed and visualized using REVIGO, where redundant GO terms are removed. The size of the circle represents the number of
enriched child GO terms contributing to the parent term. The circle color represents the uncorrected log10 P-value for each parent GO term. Semantic
space is the result of multi-dimensional scaling where similar GO terms cluster together. A full list of enriched GO terms, including false discover
rate-corrected P-values are presented in Additional file 5. (B) Top 10 most over-represented KEGG pathways, and the number of significantly
differentially expressed genes/proteins contributing to each pathway. The full list of over-represented KEGG pathways is presented in Additional file 6.
Validation of RNAseq differential expression with real-time qPCR for (C) IFNB1, (D) IFIT2 and (E) IFIT3. Real-time PCR differential expression was
calculated based on relative expression to 0 hpi and normalized to GAPDH. Log2-fold change is presented; *P <0.05, **P <0.01.
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Figure 6 Hendra virus induces apoptosis in PaKiT03, but not HEK293T cells. (A) TRAIL-mediated apoptosis pathway. (B) TRAIL relative protein
expression in PaKiT03 cells measured by SILAC. (C) mRNA fold change relative to 0 hpi and normalized to GAPDH of TRAIL, TNFRSF10A, TNFRSF11B and
CASP13 in PaKiT03 cells at 24, 48 and 72 hpi. (D) Cell viability relative to 0 hpi of PaKiT03 and HEK293T at 24, 48 and 72 hpi with HeV at a multiplicity of
infection (MOI) of 5. One-way analysis of variance (ANOVA) was used to compare cell viability between time points. (E) Relative activity of caspase 3/7
normalized to cell viability for PaKiT03 and HEK293T at 0, 24, 48 and 72 hpi with HeV at an MOI of 5. One-way ANOVA was used compared the relative
activity of caspase 3/7 between the PaKiT03 and HEK293T cells at each time point. (F) Western blot of PARP1 cleavage at 0, 8 and 24 hpi in HEK293T.
The human PARP1 antibody was not cross-reactive with the PaKiT03 cells. *P <0.05, **P <0.01.
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the TNFRSF11B ortholog was also induced at 24 hpi (al-
though not statistically significantly) (Figure 3D). However,
the expression of TNFRSF10A/DR4 and other functional
TRAIL related genes/proteins remained stable in HeV-
infected HEK293Tcells (data not shown).HeV induces apoptotic cell death in PaKiT03 but not
HEK293T cells
Considering many apoptotic components (mRNA and
proteins) were up-regulated in PaKiT03 but not HEK293T
cells, we next set out to test whether HeV actually induces
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Figure 7 TUNEL staining of HeV-infected (A) PaKiT03 and (B) HEK293T cells. Cells were infected with HeV for either 8, 24 or 48 h using an
MOI of 5. TUNEL staining was achieved using the Click-iT® TUNEL Alexa Fluor® 488 kit (green, fluorescence) and HeV-N was immunodetected as
described above (red, fluorescence). DNase I treatment was used as a positive control on HEK293T cells that demonstrated clear nuclear staining.
Owing to the decrease in cell viability at 24 hpi and beyond in the HEK293T cells, reliable TUNEL staining could not be performed after 8 hpi.
Scale bar is 30 μm in all panels.
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cleavage of PARP1 (HEK293T only) and terminal deoxy-
nucleotidyl transferase dUTP nick end labeling (TUNEL).
Both cell lines were infected at a multiplicity of infection
(MOI) of 5 for 24, 48 and 72 h and apoptosis was mea-
sured by a Caspase-Glo®3/7 luminescence assay. Cyto-
pathic effects typical of HeV were observed after 24 hpi
and increased at 72 hpi (data not shown). To account forthe decrease in cell viability within infected cells, we first
measured cell viability using a CellTiter-Glo® lumines-
cence assay and then normalized the caspase 3/7 lumines-
cence to cell viability. As expected, cell viability decreased
rapidly after 24 hpi in the HEK293T cells, but not in bat
cells. At 24 hpi, only a small and non-significant decrease
(P >0.05) in the viability of HEK293T cells was observed.
At 48 hpi a significant decrease (P <0.01) in cell viability
Wynne et al. Genome Biology 2014, 15:532 Page 11 of 21
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creased at 72 hpi (P <0.01). At 72 hpi the PaKiT03 cells
decreased in viability by approximately 50% (Figure 6D).
A significant increase in caspase 3/7 was observed at 48
and 72 hpi in the PaKiT03 compared to uninfected cells
(P <0.01; Figure 6E). By contrast, no increase in caspase
3/7 was observed in HEK293T cells at any time point. Fur-
thermore, we observed no cleavage of PARP1 in HEK293T
cells at 8 or 24 hpi (Figure 6F). The observation that HeV
significantly reduces cell viability of HEK293T cells after
24 hpi meant it was not possible to examine the apoptotic
response after this time using either PARP1 Western
blotting or TUNEL. TUNEL staining of HeV-infected
PaKiT03 cells at 24 and 48 hpi demonstrated an increased
number of apoptotic cells at 48 hpi (Figure 7A). This is in
agreement with results from the caspase 3/7 assay. In
most cases, TUNEL-positive cells were also infected with
HeV at 48 hpi. TUNEL staining of HeV-infected HEK293T
could only be performed at 0 and 8 hpi. After this time
point HeV infection caused many cells to detach from the
coverslips. TUNEL staining at 0 and 8 hpi revealed no
apoptotic HEK293T cells (Figure 7B). This finding is con-
sistent with the lack of PARP1 cleavage at 8 and 24 hpi in
HEK293T cells. Weak cytoplasmic staining was observed
in some HEK293T cells, but given we observed no nuclear
staining (as seen in PaKiT03 and the DNase control) we
concluded this was the result of non-specific background
staining. The human PARP1 antibody was not cross-
reactive in the bat cells, and so this method could not be
used.
HeV-induced apoptosis in additional human and bat cells
While a clear difference in HeV-induced apoptosis was
observed between the HEK293T and PaKiT03 cells, we
concede that these phenotypes may not be representa-
tive of all human and bat cells. Given this limitation, we
examined whether HeV induces apoptotic cell death
across other human and bat cell types. Owing to the
poorly characterized nature and paucity of primary bat
cell lines, we concentrated on well-characterized immor-
talized cell lines from P. alecto. Apoptosis was assessed
by the Caspase-Glo®3/7 luminescence assay. Following
HeV infection we observed significant increased caspase
3/7 activities in P. alecto fetus cells (PaFeB5) and, to a
lesser degree, brain cells (PaBrT03). Activities in both of
these cell types were highest at 48 hpi (P <0.01,
Figure 8A). In contrast to our previous observations in
HEK293T cells, the human embryonic fibroblasts (HEF)
and HeLa cells demonstrated a strong increase in cas-
pase 3/7 activities at 24 hpi (P <0.01; Figure 8B). This re-
sponse diminished in both HEF and HeLa cells at 48
and 72 hpi. A549 cells demonstrated only a slight but
statistically significant increase in caspase 3/7 activity at
48 hpi (p <0.05; Figure 8B).HeV sensitizes PaKiT03 cells to TRAIL-mediated apoptosis
In order to determine the influence of TRAIL in HeV-
induced apoptotic death of bat cells, we infected both
cell lines with HeV and simultaneously treated cells with
human recombinant TRAIL. At 24 hpi, bat cells infected
with HeV and treated with TRAIL had a significant in-
crease in caspase 3/7 activity compared to control cells
(P <0.01; Figure 9A). Similar observations were made at
48 hpi and, to a lesser extent, 72 hpi in the bat cells.
TRAIL alone also significantly increased caspase 3/7 ac-
tivity at 24 and 72 hpi, albeit to a lesser extent compared
to TRAIL combined with HeV (P <0.01). As expected, a
significant increase in caspase 3/7 activity was observed
in the HeV-infected PaKiT03 cells at 48 and 72 hpi
(P <0.05; Figure 9A). By contrast, human cells infected
with HeV and treated with TRAIL showed no increase in
caspase 3/7 activity at any time point (data not shown).
Finally, we set out to demonstrate that human
(HEK293T) cells are capable of TRAIL-induced apop-
totic cell death following viral infection. For this experi-
ment we utilized the bat orthoreovirus Nelson Bay virus
(NBV) [22]. NBV is also known as Pteropine orthoreovirus
NB (PRV1NB) [23]. Previous studies have demonstrated
that mammalian reoviruses can induce TRAIL-mediated
cell death in HEK293T cells. HEK293T cells were infected
with NBV at an MOI of 5 and treated with human recom-
binant TRAIL for 24 hpi. A significant increase in caspase
3/7 activity was observed in these human cells simultan-
eously infected with NBV and treated with TRAIL com-
pared to human cells infected with NBV and treated with
TRAIL alone (P <0.01; Figure 9B).
Up-regulation of TRAIL in HeV-infected bat lungs
To determine whether TRAIL and CD40 mRNA is in-
duced during HeV infection in vivo, we utilized previ-
ously collected tissue samples from an experimental
infection of the Australian black flying fox. Kidney and
lung tissue samples from four experimental HeV-
infected and two naïve control bats were obtained from
previous, unpublished studies. Bats were infected with
HeV for 36 (n = 2) and 60 hours (n = 2). Compared to
uninfected animals we observed no increase in CD40
mRNA expression at either 36 or 60 hpi in either the
lung or kidney samples (Figure 10A,B). By contrast,
TRAIL mRNA was found to be up-regulated approxi-
mately five-fold in the lung at 60 hpi (Figure 10B). Be-
cause of the biological variation between bats, this
increase was not statistically significant. TRAIL mRNA
was not induced in the lung at 36 hpi or the kidney at
either 36 or 60 hpi.
Apoptotic cell death in vivo
Given our previous results in vitro, we next set out to in-
vestigate whether HeV could induce apoptosis in vivo
A B
Figure 8 Apoptosis in other (A) bat and (B) human cells. Relative fold change of caspase 3/7 activity of bat cells from brain (PaBrT03), fetus
(PaFeb5) and lung (PaLuT02), and common human cells from lung (A549), embryonic fibroblasts (HEF) and HeLa cells. All cells were infected with
HeV for 24, 48 and 72 hpi at an MOI of 5. Uninfected cells served as the control for each time point. Two sample t-tests were used to compare
the relative activity of caspase 3/7 between the control and infected cells at each time point. *P <0.05, **P <0.01.
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Formalin-fixed paraffin-embedded tissue sections from
the experimental HeV-infected and two naïve control
flying foxes were obtained as described above. Colori-
metric TUNEL staining was performed on spleen and
kidney sections from all bats. Unfortunately the lung
sections from this trial were not suitable for TUNEL
staining, due to artifacts created during euthanasia. Few
apoptotic cells were observed in the kidney in either the
HeV-infected (Figure 10C) or control bats (Figure 10D).
By contrast, we observed numerous apoptotic cells in
the spleen (Figure 10E,F). The number of apoptotic cells
within the spleen, however, did not appear to be greater
in the HeV-infected bats compared to the naïve controls.A
Figure 9 HeV sensitizes PaKiT03 cells to TRAIL-mediated apoptosis. C
and/or infected with virus (MOI = 5) for 24, 48 and 72 hpi. The activities of
control (no TRAIL or virus) using one-way analysis of variance for each time
Increase of caspase 3/7 activity over control in PaKiT03 cells following stim
caspase 3/7 activity over control in HEK293T cells following stimulation witDiscussion
The clinical outcome of humans following HeV infection is
significantly different to that of bats. The ability of bats to
maintain asymptomatic viral infections whilst the same
agent often causes fatal infections in human is a typical
feature of bat-borne zoonotic viruses. The molecular mech-
anisms responsible for this dichotomy remain unknown.
Despite the absence of clinical disease, the fact that bats
can shed and transmit viruses suggests bats are capable of
controlling viruses, but not eliminating them all together.
Rapid induction of the innate immune processes has been
proposed as one possible mechanism for subduing viral
replication in bats [19]. Considering the importance of bats
as natural reservoirs for many emerging viruses, elucidatingB
ells were either treated with 500 ng/ml human recombinant TRAIL
caspase 3/7 within the experimental samples were compared to the
point. *P <0.05, **P <0.01. All assays were performed in triplicate. (A)
ulation with human recombinant TRAIL and/or HeV. (B) Increase of




Figure 10 TRAIL expression and apoptosis in bats in vivo. Tissue samples were obtained from a previous unpublished HeV infection of P. alecto
bats (Australian black flying fox). The expression of CD40 and TRAIL mRNA was compared in (A) kidney and (B) lung and from bats infected with HeV
for 36 and 60 hpi compared to uninfected bats. TUNEL staining was also performed on spleen and kidney sections from the experimentally infected
and control bats. TUNEL staining of the (C) spleen and (D) kidney of a representative control bat. Arrows highlight TUNEL-positive cells in the spleen.
TUNEL staining from a representative HeV-infected bat (60 hpi) showed no increase in the number of TUNEL-positive cells in the (E) spleen and/or
(F) kidney compared to the control. Scale bar is 100 μm in all panels.
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be invaluable to the field of emerging infectious diseases. In
addition, system-wide analysis of human responses to infec-
tion only provides a picture of the pathways affected duringa pathogenic infection. Ideally we would like to have a
system-wide comparison between a pathogenic and non-
pathogenic response to the same infectious agent. With this
in mind, we compared the transcriptome and proteome
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bat following HeV infection using our recently developed
integrated systems-wide approach.
The PaKiT03 and HEK293T cells examined in this study
responded very differently to HeV. Even when only high
confidence orthologous transcripts are considered, the
transcriptomic and proteomic response was significantly
different - despite the similar expression profiles of ortho-
logs at 0 hpi. Human HEK293T cells appeared to show lit-
tle response at 8 hpi, followed by a largely suppressive
response at 24 hpi. PaKiT03 cells, however, demonstrated
a strong activation of several immune pathways at 8 and
24 hpi, followed by the induction of extrinsic apoptosis at
24 hpi and beyond.
To our knowledge, this is the first study to examine pro-
grammed cell death within a bat species. Apoptosis plays an
integral part of the host-pathogen interaction. Induction of
the innate immune response often leads to the activation of
apoptotic processes, typically through members of the TNF
family. We have demonstrated that, following HeV infection,
PaKiT03 cells up-regulated components of the TRAIL-
mediated apoptosis pathway. By contrast, the HEK293Tcells
appeared to either down-regulate a number of pro-
apoptotic proteins or up-regulate anti-apoptotic compo-
nents. Induction of TRAIL-mediated apoptosis following
viral infection of human cells has been reported previously.
In most cases, viral infection induces the expression of the
death receptors DR4 and DR5, which in turn sensitizes the
cells to TRAIL-mediated apoptosis [24,25]. Infection of hu-
man cells with hepatitis C and mammalian reoviruses in-
duces mRNA and protein expression of the functional
TRAIL receptors DR4 and DR5 [24,26]. Paramyxoviruses
such as human respiratory syncytial virus have also been
shown to induce expression of DR5 and DR4 in human lung
cells [25]. In the PaKiT03 cells, we observed a greater than
two-fold increase in TNFRSF10A/DR4 mRNA expression
at 24 hpi. Interrogation of the P. alecto genome along with
our de novo assembled transcriptome suggested that, like
mice, bats contain only one functional death receptor.
TNFRSF10A/DR4 may therefore act as the sole functional
TRAIL receptor in bats.
The expression of TRAIL is regulated through NF-κB
transcription factors [27] in response to viral infection. Vi-
ruses such as measles and respiratory syncytial virus in-
duce functional TRAIL expression in human cells [25,28].
Here, we observed a significant increase in TRAIL protein
expression at 24 hpi in the bat cells. The activation of NF-
κB pathways within the bat cells, including the up-
regulation of CD40, NFKB2 and RelB transcripts, may
have contributed to the increased TRAIL protein expres-
sion. Surprisingly, we observed no increase in TRAIL
mRNA at 8, 24, 48 or 72 hpi within the PaKiT03. This
finding suggests that the regulation of TRAIL protein ex-
pression possibly occurs post-transcriptionally. By usingpreviously collected lung and kidney tissue samples from
HeV-infected bats, we examined the expression of TRAIL
and CD40 mRNA in the context of an in vivo infection.
While no increase in CD40 mRNA expression was ob-
served in either kidney or lung, we found an approxi-
mately five-fold up-regulation of TRAIL mRNA in bat
lungs infected with HeV for 60 h. Previous, unpublished
data from this trial demonstrated that the HeV antigen
could only be detected in the lung tissue at 60 hpi through
immunohistochemistry (M. Baker, unpublished data). The
coordinated up-regulation of TRAIL mRNA at the site of
HeV infection within the natural host highlights the im-
portance of TRAIL in HeV infection in vivo.
The interaction between TRAIL and its functional re-
ceptors is crucial for inducing apoptotic cell death
through caspase 8 [29]. The treatment of cells with hu-
man recombinant TRAIL and subsequent HeV infection
demonstrated that HeV sensitizes PaKiT03 cells to
TRAIL-mediated apoptosis at 24 hpi. Presumably, this
‘sensitivity’ is achieved through the increased expression
of TNFRSF10A/DR4 as discussed above. A similar obser-
vation was made by Clarke et al. [24], where reovirus in-
fection increased the sensitivity of human cells to
apoptosis by increasing the expression of DR4 and DR5.
In the present study, HEK293T cells showed no in-
creased susceptibility to TRAIL-mediated apoptosis fol-
lowing HeV infection. Importantly, we showed that this
finding is not a general feature of human HEK293T cells.
Indeed, when we treated these cells with human recom-
binant TRAIL and infected them with NBV, we saw an
increase in TRAIL-mediated apoptosis (evidenced by in-
creased caspase 3/7 activity). We can therefore conclude
that the HEK293T cells are indeed capable of TRAIL-
induced cell death, but for unclear reasons this process
does not occur in response to HeV.
Pro-apoptotic components down-stream of the death
receptors were also induced in the bat cells, including
BBC3, BIRC3 and caspase 13. The latter, also known as
evolutionarily related interleukin1β converting enzyme,
was originally discovered in humans [30], but was later
shown to be of bovine origin and is the likely ortholog
of human caspase 4 [31]. In the present study, a tran-
script resembling caspase 13 was induced at 8 and 24
hpi in the bat cells. Previous studies have shown that
over-expression of caspase 13 in human HEK293 and
MCF7 cells successfully induces apoptosis [30]. Further-
more caspase 13 appeared to be activated by caspase 8
[30], suggesting this enzyme may play a role in death
receptor-mediated apoptosis pathways, such as TRAIL.
In principle, the ability of PaKiT03 cells to induce apop-
totic cell death following HeV infection could provide a
mechanism by which cells can effectively inhibit or subdue
viral replication. To determine whether this phenotype
was representative of all bat cells we examined HeV-
Wynne et al. Genome Biology 2014, 15:532 Page 15 of 21
http://genomebiology.com/2014/15/11/532induced apoptosis across three more bat (derived from P.
alecto) and three more human cell lines. The apoptotic re-
sponse varied widely between the cell lines. Strong caspase
3/7 responses were observed in HEF and HeLa cells at 24
hpi. The bat fetus cells (PaFeB5) also showed a strong cas-
pase 3/7 response, while the brain (PaBrT03) and lung
(PaLuT02) cells were less responsive. While these findings
demonstrate that HeV-induced apoptosis is not specific to
bat cells, they do highlight the importance of programmed
cell death in viral infection more broadly. In agreement, a
previous study found NiV partially activates and induces
apoptotic cell death of human dendritic cells through up-
regulation of caspase 3 and down-regulation of bcl2 [32].
Considering the induction of apoptosis in PaKiT03
cells in vitro, along with the up-regulation of TRAIL
mRNA in HeV-infected bat lung tissues, we attempted
to examine the apoptotic response of bats to HeV
in vivo. TUNEL staining of formalin-fixed paraffin-
embedded tissue sections revealed no increase in the
proportion of apoptotic cells in either the kidney or
spleen of HeV-infected bats compared to uninfected
controls. In fact, very few apoptotic cells were observed
in the kidney in any sample, while numerous apoptotic
cells were found in the spleen. Unfortunately, the lung
sections (where we might have expected to see the most
striking differences) from this trial were not suitable for
TUNEL staining, due to artifacts created during euthan-
asia. While this experiment could not definitively dem-
onstrate HeV-induced apoptosis in vivo in bats, future
examination of tissues from other HeV model species
such as ferret and mice - where a more pronounced viral
load is achieved - may help clarify the influence of apop-
tosis in vivo.
We cannot exclude the possibility that the subtle differ-
ences in viral transcription between the bat and human cells
are influencing the host response. Viruses utilize a number
of strategies for counteracting immune and apoptotic sig-
nals. Previous studies have demonstrated that paramyxovi-
ruses can use the accessory proteins from the P/V/C gene to
inhibit apoptosis [33,34]. The V protein of mumps virus is
also known to block IFN expression [35]. When we com-
pared the HeV transcription profile between the cell lines,
there appeared to be fewer transcripts for the P/V/W region
in human cells compare to bat cells. Considering the im-
portant role of the V protein in immune evasion, this tran-
scriptional variation may influence the host response,
particularly in regard to IFN production. Phenotypically, we
also observed differences in the cytopathic effect between
human and bat cells following HeV infection at 24 hpi. Ex-
tensive syncytia were observed in the human but not bat
cells. Cell fusion and syncytia are mediated by the HeV-F
protein. It is therefore interesting to note that we observed
higher abundance of F transcript in the human cells com-
pared to bat cells. Differences in the abundance of Ftranscript may therefore influence the difference in cyto-
pathic effect observed.
The induction of IFN-β1 and down-stream ISGs in hu-
man cells was unexpected. A number of transfection stud-
ies have demonstrated that the henipavirus P gene products
(P, V, W and C) can inhibit both the IFN induction and IFN
signaling pathways in human cell lines (including HEK293T
and 2fTGH) [36,37]. More recent studies on HEK293T
cells, however, have shown that, while productive henipa-
virus infection can effectively block IFN production after 3
hpi, it only partially blocks IFN signaling, as measured by
the expression of ISGs at 24 hpi [38]. Similar studies on a
range of P. alecto cell types, including lung (PaLuT02), pri-
mary kidney (PaKi) and fetus (PaFe and PaFeT) [39], dem-
onstrated that both IFN production and signaling were
blocked by henipavirus infection at 3 and 24 hpi, respect-
ively [40]. By contrast, our findings demonstrate that in hu-
man HEK293T cells IFN production and signaling occur at
24 hpi, thus suggesting the host is capable of overcoming
the antagonistic effects of HeV at this later time point. It is
worth noting that interferon regulatory factor 3 (IRF3), an
important transcription factor responsible for IFN-β induc-
tion, was down-regulated at the protein level at 24 hpi in
human cells. This finding is somewhat at odds with the in-
duction of IFN-β1 at 24 hpi in human cells. NiV has been
shown to block IFN production through the accessory V
and W proteins by targeting IRF3 [41]. While HeV may use
a similar mechanism, a two-fold reduction in IRF3, as
observed in this study, does not appear sufficient to
completely abolish IFN production in human cells. IFN
antiviral response is also mediated to some degree by the
Ras/MAPK pathways. Studies of persistent Ebola virus
(Mayinga strain) infection of bat lung fibroblasts found that
activation of the Ras/MAPK pathway, which antagonizes
the IFN response, was required for productive infection
[13]. In the present study, we found many of the down-
regulated transcripts/proteins in the human cells were
mapped to MAPK pathways. Inactivation of these pathways
may have contributed to the increased IFN response ob-
served in human cells at 24 hpi.
It should be acknowledged that this study, although
comprehensive, examined only one cell type from both
bats and humans. The major differences in response be-
tween the bat and human cells may to some degree sim-
ply reflect differences in cell type. In any mammal, it is
highly likely that not all cell types will respond to viral
infection in a similar fashion. Furthermore, mechanisms
deduced from cell lines may not reflect what occurs
in vivo. With this in mind, we stress that caution must
be taken when extending conclusions from in vitro stud-
ies (such as ours) to other cell types, and more generally
in vivo models. However, in vitro studies provide signifi-
cant insight into host mechanisms at the molecular level,
ultimately generating numerous hypotheses that can be
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in vitro studies are necessary (at least in the first in-
stance) when examining a highly pathogenic virus (such
as HeV) that requires high levels of bio-containment.
Turning to the many novel genes and proteins identi-
fied, that we uncovered a great many new genes that are
also positively identified by liquid chromatography tan-
dem mass spectrometry (LC-MS/MS) re-enforces the
power of our PIT-based approach to comprehensively
identify, annotate and quantitate changes in human and
non-model host species. This is the first time a single
virus has been comprehensively analyzed by RNAseq
and high-throughput quantitative proteomics in cells
lines from two species. For the first time, we can com-
pare at a systems level, the response between a resistant
reservoir host (bat) and a susceptible spillover host (hu-
man). By identifying the crucial cellular pathways whose
differential activation correlates with outcome, we open
new opportunities for therapeutic intervention, through
testing the many pathway-specific licensed drugs already
available. Moreover, our approach enables side-by-side
comparison of any mammal with humans to determine
how similar or divergent two species are when they are
infected with a virus or exposed to a drug (or both). In
principle, this could guide better selection of animal
models and improve our ability to predict how humans
will respond to treatments developed in animal models.
Finally, our dataset provides transcriptomic and prote-
omic evidence of approximately 5,900 genes and pro-
teins. This includes evidence for nearly several hundred
genes and proteins not listed in the UniProt dataset for
P. alecto. This represents a major leap forward in our
understanding of the genetic content of bats - significant
natural hosts of current and potentially future zoonotic
agents.
Conclusion
By application of PIT analysis, we have shown that
PaKiT03 and HEK293T cells respond significantly differ-
ently to HeV at both the mRNA and protein level. Hu-
man HEK293T cells demonstrated little early response
followed by a global suppression of mRNA and protein
abundance. Bat PaKiT03 cells, by contrast, demonstrated
a robust innate immune response, which led to the exe-
cution of extrinsic TRAIL apoptosis pathways. At 48 and
72 hpi, PaKiT03 cells, but not HEK293T cells, demon-
strated a significant increase in apoptotic cell death.
However, when further cell lines from bats and humans
were examined, we found that at least some human lines
(HEF and HeLa) were susceptible to HeV-mediated
apoptosis. Moreover, examination of tissue samples from
HeV-infected bats failed to reveal widespread apoptosis
at least for the spleen and kidneys. Notwithstanding this,
we have shown how to compare the response of twodistinct species to the same infectious agent using RNA-
seq and high-throughput quantitative proteomics. We
have used this analysis to highlight the potential to iden-
tify and test pathways that in principle could have a sig-
nificant bearing on the outcome of disease. We believe
this approach will enable the identification and investi-
gation of pathways that contribute at a molecular level
to the devastating differential pathogenicity of zoonotic
bat viruses when they infect humans.
Methods
Cell culture and SILAC
The P. alecto immortalized kidney derived cell line PaKiT03
[39] and the human immortalized embryonic kidney cell
line HEK293T were predominantly used in this study. Cells
were cultured in either Dulbecco’s modified Eagle’s medium
(DMEM)/F12 (PaKiT03) or DMEM (HEK293T) media
(Pierce, Rockford, USA) containing 10% (v/v) dialyzed fetal
calf serum (FCS), and 10 mM HEPES. To achieve isotope
incorporation cells were cultured in either 12C/14 N lysine
and arginine (designated ‘light’), 13C/14 N lysine and argin-
ine (designated ‘mid’) or 13C/15 N lysine and arginine (des-
ignated ‘heavy’). Cells were cultured for at least 10
doublings.
Additional bat cell lines utilized in this study included
P. alecto immortalized brain (PaBrT03), fetus (PaFeB5)
and lung (PaLuT02) cells [39]. All bat cells were cultured
in DMEM/F12 containing 10% FCS. Additional human
cells utilized in this study include A549, HEF and HeLa
cells. The A549 and HEF cells were cultured in DMEM
containing 10% FCS. HeLa cells were cultured in Eagle's
minimal essential medium containing 10% FCS.
Virus infection for SILAC cells
Approximately 2 × 107 PaKiT03 and HEK293T cells were
either mock infected (light), or infected with HeV/
Australia/Horse/1994/Hendra strain for 8 h (mid) or
24 h (heavy) at an MOI of 10. The experiment was con-
ducted in duplicate in T75cm2 flasks. Cells were har-
vested by trypsinization and split in two. One half was
resuspended in 2% SDS-NuPAGE reducing buffer (Life
Technologies, Carlsbad, USA) and boiled for 5 min
at 100°C. The remainder was resuspended in RLT
buffer (Qiagen, Limburg, Netherlands) containing 1% β-
mecaptoethanol.
Immunofluorescence microscopy
SILAC-labeled PaKiT03 and HEK293T cells were seeded
onto 13 mm diameter coverslips in 24-well plates. Cells
were either mock (light cells) or infected for 8 h (mid) or
24 h (heavy) with HeV/Australia/Horse/1994/Hendra
strain at an MOI of 10. Media was removed and cells were
fixed in 4% paraformaldehyde (w/v) in phosphate-buffered
saline (PBS) for 1 h. Coverslips were then washed three
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for 10 min, blocked with 0.5% (w/v) bovine serum albumin
(BSA) for 30 min, and incubated with anti-N protein
(Australian Animal Health Laboratory) diluted 1:2,000 in
0.5% (w/v) BSA for 1 h. Cells were washed three times with
PBS and treated with a Alexa 488-labeled goat anti-rabbit
antibody diluted 1:200 (Life Technologies) in 0.5% (w/v)
BSA for 1 h. Finally, cells were washed twice with PBS,
once with H2O, and stained with 4′,6-diamidino-2-pheny-
lindole dihydrochloride for 10 min. Coverslips were washed
in PBS, mounted in Vectashield (Vector Labs, Burlingame,
USA) and imaged with a Leica SP5 confocal microscope.
RNA isolation and sequencing
Total RNA was isolated from cells in RLT buffer using the
RNAeasy kit (Qiagen) with DNase I treatment as per the
manufacturer’s instructions. The quality and quantity of
RNA was assessed for all samples using a Bioanalyser
(Agilent, Santa Carla, USA). mRNA was sequenced as 100
base pair paired-end reads across a single lane on a HiSeq
2000 (Illumina, San Diego, USA). Resulting reads were
trimmed for adapters and quality assessed using FastQC.
Reads have been deposited in the NCBI Sequence Read
Archive and assigned the accession [SRP044809].
Gene Ontology and KEGG enrichment
Official gene identifications (IDs) were retrieved for all sig-
nificantly differentially expressed transcripts and proteins.
Gene IDs for transcripts and proteins that were significantly
up-regulated at one or more time points were combined
into a single list. A list of significantly down-regulated gene
IDs was also compiled. Biological process GO enrichment
was performed separately on the up- and down-regulated
transcript and protein lists using the unranked target and
background analysis in GOrilla [42]. Background gene lists
were compiled by retrieving all gene IDs from either the
human (hg19) or P. alecto genome. Enriched GO categories
were compiled into Excel spreadsheets and visualized using
REVIGO [43]. The up- and down-regulated transcript and
protein lists were also used to interrogate KEGG pathways
using the standard KEGG Mapper tool [44].
Transcriptome assemblies and differential
expression analysis
Raw reads from each species were first used to assemble a
de novo transcriptome on the University of Bristol high
performance computing facility, BlueCrystal, using Trinity
[45,46]. Next, for each of the samples, reads were
independently mapped against the P. alecto [GenBank:
GCF_000325575.1] or human (hg19 in Ensembl) genome
with Bowtie (version 0.12.7) and TopHat (version 1.3.2) [47].
Using the alignment outputs, transcripts were assembled for
each sample and merged into a single transcriptome for
PaKiT03 and HEK293T using Cufflinks and Cuffmerge(version 1.2.1) [48]. Both Trinity and Cufflinks-assembled
transcriptomes were translated as previously described [21]
using the ‘getorf ’ facility in EMBOSS and ORFs less than
200 nucleotides were removed.
To understand changes in transcript abundance, reads
from each time point were mapped separately against
the Trinity-generated transcriptome using Bowtie2 (ver-
sion 2.1.0). Resulting SAM files were converted to BAM,
sorted, indexed, and the number of reads mapping to
each Trinity transcript was compiled using SAMtools
(version 0.1.18). Differential expression analysis was con-
ducted with DESeq (version 1.14.0). Count data was nor-
malized and pairwise comparisons between time points
calculated as described previously [49]. Transcripts with
adjusted P-values <0.05 were considered significant.
Quantitative proteomics
The three SDS boiled protein samples were combined in
a 1:1:1 ratio, separated by SDS-PAGE and analyzed by
LC-MS/MS. The gel lane was cut into 20 slices, and
each slice was subjected to in-gel tryptic digestion and
the samples processed as described previously [21]. In
addition, the samples from PakTi03 cells were run again
(another 20 slices) as a technical repeat to maximize our
data return for this species.
The raw data files were processed and quantified using
MaxQuant and searched against the three databases de-
scribed below. Peptide precursor mass tolerance was set at
10 ppm, and MS/MS tolerance was set at 0.8 Da. Search cri-
teria included carbamidomethylation of cysteine (+57.0214)
as a fixed modification and oxidation of methionine
(+15.9949) and appropriate SILAC labels (13C6-lysine,
13C6-
arginine for mid-labeled cells and 13C6, 15 N2-lysine,
13C6,
15
N4-arginine for heavy-labeled cells as variable modifica-
tions). Searches were performed with full tryptic digestion,
and a maximum of two missed cleavages was allowed. The
reverse database search option was enabled, and all peptide
data were filtered to satisfy a false discovery rate of 1%. All
raw proteomics data has been deposited into the PRIDE
(PRoteomics IDEntifications) database and assigned the ac-
cession number [PXD001165].
The lists of proteins derived from a Trinity- or
Cufflinks-based assembly of mRNA were searched se-
quentially on their own to determine which ORFs might
be real (that is, at least one peptide identified). From this
analysis we obtained a short list of ORFs that had been
identified and combined these with the official UniProt
lists to create a combined list of proteins from UniProt,
from the Trinity transcripts and from the Cufflinks-
assembled transcripts. To identify the maximum number
of peptides, mass spectra were searched against a combin-
ation of three protein databases: UniProt-derived lists of
proteins for HeV and either H. sapiens or P. alecto; ORFs
identified as real from the Cufflinks-derived mRNA; and
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Trinity-derived mRNA. Peptides were assigned by Max-
Quant into ‘proteinGroups’ that contain one or more indi-
vidual protein sequences (Additional files 7 and 8). In
most cases peptides were assigned to a proteinGroup that
contained a protein sequence from all three databases
(Additional file 9). For the PaKiT03 cells the greatest
number of proteinGroups was identified against the Trin-
ity de novo assembled transcript database. By contrast, for
the HEK293T cells the greatest number of proteinGroups
was identified against the UniProt human proteins list
(Additional file 9). Differential expression of the pro-
teinGroups was calculated from the combined peptide
abundance ratio of mid to light (8 hpi:0 hpi) and heavy to
light (24 hpi:0 hpi). A threshold of ≥ two-fold change was
employed. That is, protenGroups with SILAC ratios ≥2
or ≤0.5 were considered significant.Comparison between human and Pteropus datasets
To identify orthologs shared between bats and humans we
used the Trinity-derived lists of transcripts. ORFs (from
start codon to stop codon) were translated in all frames
from the Trinity-derived transcripts and ORFs over 66
amino acids long were compiled into a table together with
the transcript they came from. This list of ORFs was
searched using BLAST to find the closest homolog in the
human UniProt list. This process was repeated for both
the human and the bat list of transcripts. Finally, for each
entry in the human UniProt list of proteins we selected
the best match from the Trinity-derived ORFs for each
species. In this way we were able to generate a master list
of transcripts and ORFs that were the best matches to the
human UniProt list of proteins. This approach allowed us
to connect orthologous genes and ORFs from the human
Trinity-derived transcripts to the P. alecto Trinity-derived
transcripts and ORFs. We were then able to designate the
P. alecto genes and proteins with their nearest human ho-
mologs, enabling a pathways analysis based on the as-
sumption that all the identified P. alecto genes and
proteins had direct human homologs (Additional file 4).
Alongside this analysis, we examined the list of P. alecto
Trinity-derived ORFs that had been identified as being
real on the basis that at least one peptide from each ORF
had been detected by the MaxQuant analysis. In essence,
each transcript that generated an ORF identified by Max-
Quant was compiled into a list of transcripts, ORF and
peptide evidence for each ORF. We then used sequential
BLAST searches to identify each ORF by searching against
the P. alecto proteome and the human proteome
(Additional file 10). We separated out any ORF which had
a less than 60% identity to either official proteome list and
searched only those against the non-redundant protein
lists, again using BLAST (Additional file 11).Bat tissue samples
Tissue samples from P. alecto were obtained from a previ-
ous experimental HeV infection at the Australian Animal
Health Laboratory. Seven age-matched Australian black fly-
ing foxes were each intranasally infected with 27,300 Tissue
culture infective dose (TCID50)/ml of HeV (Redlands
strain). Two uninfected bats served as controls. Animals
were euthanized at 12 (n = 3), 36 (n = 2) and 60 (n = 2) hpi,
and tissues dissected and stored. RNA was extracted (as de-
scribed above) from lung and kidney for the 36 hpi, 60 hpi
and control bats. Lung, kidney and spleen tissues were for-
malin fixed and paraffin embedded for all bats. All animal
experimentation was approved by the Commonwealth Sci-
entific and Industrial Research Organisation-Australian Ani-
mal Health Laboratory Animal Ethics Committee (protocol
AEC1558).
Real-time PCR
Differential gene expression was assessed using reverse
transcriptase real-time PCR. Primers were designed
using Primer3 (Additional file 12). Reaction parameters
were identical for all genes. Briefly, 5 μg of total RNA
was reverse transcribed using Superscript III (Life Tech-
nologies) primed with oligo-dT as per the manufacturer’s
instructions. Triplicate SYBR green real-time PCR reac-
tions were performed in a 25 μl reaction, containing 1X
EXPRESS SYBR green master mix (Life Technologies),
200 nM forward and reverse primer, and 20 ng template.
Cycling parameters were 95°C for 10 min, then 40 cycles
of 95°C for 30 s, 55°C for 30 s and 72°C for 1 min,
followed by melt curve analysis. Differential expression
was calculated relative to uninfected T0, normalized to
GAPDH using the relative expression software tool
REST [50].
Western blotting
Protein quantity was determined for SDS boiled lysates
using the EZQ Protein Quantitation Kit (Life Technologies)
following the manufacturer’s instructions. For each sample a
total of 10 μg of protein lysate was subjected to SDS-PAGE
and transferred to a polyvinylidene difluoride membrane.
Membranes were blocked with 5% skim milk powder for
1 h. Membranes were washed three times (10 min each)
with Tris-buffered saline/Tween 20 (TBST), and then incu-
bated for 1 h with primary antibody diluted in TBST. The
following primary rabbit antibodies were used: CD40
(1:5,000, Thermo Fisher, Waltham, USA), A20 (1:1,000, Cell
Signaling, Danvers, USA) and β2-tubulin (1:2,000, Cell
Signaling). Membranes were washed three times with TBST
and then incubated for 1 h with goat anti-rabbit horseradish
peroxidase-conjugated secondary antibody diluted in TBST.
Membranes were finally washed twice with TBST, once with
TBS and developed with ECL-Plus chemiluminescent
substrate (Thermo Fisher) as per the manufacturer’s
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phon FLA9000 gel imaging scanner (GE Healthcare, Little
Chalfont, UK).Apoptosis and viability assay
The Caspase-Glo 3/7 Assay (Promega, Madison, USA)
was used to determine the activity of caspase 3/7. Cell
viability was determined using the CellTiter-Glo Lumi-
nescent Cell Viability Assay (Promega). For both assays,
approximately, 30,000 cells/well were seeded into white
96-well plates. Cells were infected with HeV or NBV
[22] for 24, 48 and 72 h at an MOI of approximately 5.
Both assays were performed exactly as per the manufac-
turer’s instructions, in triplicate. TRAIL stimulation
with performed using SuperKillerTRAIL (AdipoGen,
San Diego, USA) at 500 ng/ml diluted in media. One-
way analysis of variance was used to compare the cas-
pase 3/7 luminescence over the control.TUNEL staining
TUNEL was used to identify apoptotic PaKiT03 and
HEK293T cells following viral infection. Approximately
1.5 × 105 cells were seeded onto 15 mm diameter cover-
slips in individual wells of a 24-well plate. Cells were ei-
ther mock or infected for 8, 24 or 48 h with HeV/1994/
Australia strain at an MOI of 5. Media was removed
and cells were fixed in 4% (w/v) paraformaldehyde in
PBS for 1 h. Cells were then gently washed three times
in PBS. Staining was performed using a Click-iT
TUNEL Alexa Fluor® 488 kit as per the manufacturer’s
instructions (Life Technologies). Optional immuno-
fluorescence was performed against the HeV-N protein
as described above except a secondary Alexa Fluor 568
Goat Anti-Rabbit antibody (Life Technologies) was
used.
Colormetric TUNEL staining was performed on
Australian black flying fox spleen and kidney tissue sec-
tions from a previous unpublished experimental HeV
infection. Following routine histological processing and
paraffin embedding, blocks were sectioned at 4 μm on
to positively charged slides and placed in a 37°C oven to
dry. Sections were placed in a 60°C incubator for 10 min
prior to de-waxing and rehydration through a series of
graded alcohols to water. The TUNEL staining for apop-
totic cells was carried out as per the manufacturer’s in-
structions for tissue sections using the DeadEnd
Colorimetric TUNEL System (Promega) with the excep-
tion of a substitution of 3-amino-9-ethylcarbazol for
3,3′-diaminobenzidine as the chromogen. The sections
were subsequently counterstained with Lillie-Mayer’s
hematoxylin to enable visualization of the morpho-
logical structure of the tissue.Additional files
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